GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

International: Japan pledged in September to donate three million doses from its national stockpile of LC16m8 vaccines, first ...

The revised timeline allows eligible women to receive their first dose by the end of March 2025 and complete the remaining ...

“Adults aged 50 to 59 with certain underlying medical conditions can face debilitating consequences from RSV, so we are pleased to offer those in Japan a vaccine for the first time.” "GSK ...

The number of new HIV infections and deaths has fallen across the world, marking significant progress in the fight against ...

The latest health news includes the tragic death of two Australians from methanol poisoning in Laos, approval of GSK's RSV ...

The days of free COVID-19 vaccine shots in Japan may be numbered. The Finance Ministry on Nov. 7 asked an advisory panel to start discussing possible charges for the COVID-19 shots, like the ones ...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus vaccine, recombinant ...

City officials recently announced the latest batch of 23 local firms to earn the Time-Honored Brands designation. New ...

Experts suggested that the low levels of vaccine confidence expressed in Japan may be the result of a past vaccine safety scare, and could stem from there being little information available to ...